GFACX
Price
$65.94
Change
-$0.63 (-0.95%)
Updated
Feb 4 closing price
Net Assets
335.97B
MRLTX
Price
$16.67
Change
-$0.30 (-1.77%)
Updated
Feb 4 closing price
Net Assets
129.68M
Interact to see
Advertisement

GFACX vs MRLTX

Header iconGFACX vs MRLTX Comparison
Open Charts GFACX vs MRLTXBanner chart's image
American Funds Growth Fund of Amer C
Price$65.94
Change-$0.63 (-0.95%)
VolumeN/A
Net Assets335.97B
AMG Renaissance Large Cap Growth N
Price$16.67
Change-$0.30 (-1.77%)
VolumeN/A
Net Assets129.68M
GFACX vs MRLTX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. MRLTX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and MRLTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 336B vs. MRLTX (130M). GFACX (0.00) and MRLTX (0.00) have matching dividends . GFACX was incepted earlier than MRLTX: GFACX (25 years) vs MRLTX (17 years). GFACX (1.35) is less costly to investors than MRLTX (1.11). MRLTX is a more actively managed with annual turnover of: 47.00 vs. GFACX (32.00). GFACX has a lower initial minimum investment than MRLTX: GFACX (250) vs MRLTX (2000). GFACX annual gain was more profitable for investors over the last year : -1.70 vs. MRLTX (-10.90). MRLTX return over 5 years is better than : 6.78 vs. GFACX (2.41).
GFACXMRLTXGFACX / MRLTX
Total Expense Ratio1.351.00135%
Annual Report Gross Expense Ratio1.351.11122%
Fund Existence25 years17 years-
Gain YTD-2.021-2.22991%
Front LoadN/AN/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets336B130M258,462%
Annual Yield % from dividends0.000.00-
Returns for 1 year-1.70-10.9016%
Returns for 3 years34.9310.39336%
Returns for 5 years2.416.7835%
Returns for 10 years91.8570.87130%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DBLVF0.870.01
+1.03%
Doubleview Gold Corp.
AZNCF187.10N/A
N/A
AstraZeneca Plc
DCYHY26.45N/A
N/A
Discovery Holdings Ltd.
MOPHY9.19N/A
N/A
Monadelphous Group Ltd
NOWVF0.22N/A
-0.05%
NowVertical Group Inc.